Incidence, Trends, and Outcomes of Infection Sites Among Hospitalizations of Sepsis: A Nationwide Study
Overview
Authors
Affiliations
Purpose: To determine the trends of infection sites and outcome of sepsis using a national population-based database.
Materials And Methods: Using the Nationwide Inpatient Sample database of the US, adult sepsis hospitalizations and infection sites were identified using a validated approach that selects admissions with explicit ICD-9-CM codes for sepsis and diagnosis/procedure codes for acute organ dysfunctions. The primary outcome was the trend of incidence and in-hospital mortality of specific infection sites in sepsis patients. The secondary outcome was the impact of specific infection sites on in-hospital mortality.
Results: During the 9-year period, we identified 7,860,687 admissions of adult sepsis. Genitourinary tract infection (36.7%), lower respiratory tract infection (36.6%), and systemic fungal infection (9.2%) were the leading three sites of infection in patients with sepsis. Intra-abdominal infection (30.7%), lower respiratory tract infection (27.7%), and biliary tract infection (25.5%) were associated with highest mortality rate. The incidences of all sites of infections were trending upward. Musculoskeletal infection (annual increase: 34.2%) and skin and skin structure infection (annual increase: 23.0%) had the steepest increase. Mortality from all sites of infection has decreased significantly (trend p<0.001). Skin and skin structure infection had the fastest declining rate (annual decrease: 5.5%) followed by primary bacteremia (annual decrease: 5.3%) and catheter related bloodstream infection (annual decrease: 4.8%).
Conclusions: The anatomic site of infection does have a differential impact on the mortality of septic patients. Intra-abdominal infection, lower respiratory tract infection, and biliary tract infection are associated with higher mortality in septic patients.
Wang W, Wang Y, Xu Y, Shen W, Lu G, Gu Y Sci Rep. 2025; 15(1):3315.
PMID: 39865114 PMC: 11770091. DOI: 10.1038/s41598-025-87310-2.
Optical Bionanosensors for Sepsis Diagnostics.
Derichsweiler C, Herbertz S, Kruss S Small. 2025; 21(8):e2409042.
PMID: 39745136 PMC: 11855245. DOI: 10.1002/smll.202409042.
Tita A, Isac S, Isac T, Martac C, Teodorescu G, Jipa L Medicina (Kaunas). 2024; 60(11).
PMID: 39596925 PMC: 11596881. DOI: 10.3390/medicina60111740.
Clinical phenotypes of sepsis: a narrative review.
Liu B, Zhou Q J Thorac Dis. 2024; 16(7):4772-4779.
PMID: 39144306 PMC: 11320222. DOI: 10.21037/jtd-24-114.
Berninghausen C, Schwab F, Gropmann A, Leidel B, Somasundaram R, Hottenbacher L Infection. 2024; 52(4):1385-1396.
PMID: 38441730 PMC: 11289221. DOI: 10.1007/s15010-024-02197-x.